Matches in Wikidata for { <http://www.wikidata.org/entity/Q63573214> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- Q63573214 description "clinical trial" @default.
- Q63573214 description "ensayu clínicu" @default.
- Q63573214 description "klinisch onderzoek" @default.
- Q63573214 description "клінічне випробування" @default.
- Q63573214 name "A Study to Investigate the Pharmacokinetics, Efficacy, and Safety of Atezolizumab Subcutaneous in Patients With Stage IV Non-Small Cell Lung Cancer" @default.
- Q63573214 type Item @default.
- Q63573214 label "A Study to Investigate the Pharmacokinetics, Efficacy, and Safety of Atezolizumab Subcutaneous in Patients With Stage IV Non-Small Cell Lung Cancer" @default.
- Q63573214 prefLabel "A Study to Investigate the Pharmacokinetics, Efficacy, and Safety of Atezolizumab Subcutaneous in Patients With Stage IV Non-Small Cell Lung Cancer" @default.
- Q63573214 P1132 Q63573214-03F9D4BE-DA01-4466-9ECD-4BD8AD3E3D08 @default.
- Q63573214 P1476 Q63573214-7FEA91BC-EBFD-4B60-9383-A539D6436605 @default.
- Q63573214 P17 Q63573214-103DF95F-3903-4E77-A664-834EEEA393DC @default.
- Q63573214 P17 Q63573214-18AE5865-F712-4002-9D9B-6BFD5CEDB5D9 @default.
- Q63573214 P17 Q63573214-441B527E-16E7-4C17-BF2F-154A5787A209 @default.
- Q63573214 P17 Q63573214-501742AE-AB04-43D6-997A-1E637F68332A @default.
- Q63573214 P17 Q63573214-74B4547A-ED77-4841-92EC-7FF7F61AC53F @default.
- Q63573214 P17 Q63573214-7D1158C0-3A93-49B5-BB47-6CD11BADCB41 @default.
- Q63573214 P17 Q63573214-8B56298C-DA37-4707-8E7C-28B63B64F3B6 @default.
- Q63573214 P17 Q63573214-D024F62F-48AC-43BE-B94C-EE4B4EC4981B @default.
- Q63573214 P2899 Q63573214-71823F41-5F2D-4474-B7E7-F1F799D09AEA @default.
- Q63573214 P3098 Q63573214-281BCB36-2EA3-45D3-9E17-0B419A944E7F @default.
- Q63573214 P31 Q63573214-CE5BFFBA-4D80-4455-8F40-C15D3E0E4A70 @default.
- Q63573214 P4844 Q63573214-6482A529-D198-4C91-AD82-300B714E4963 @default.
- Q63573214 P4844 Q63573214-8877941E-2A23-4AF4-8962-4BBA240FB23E @default.
- Q63573214 P4844 Q63573214-D1716093-9A9C-4DC1-94FD-6A2969E75187 @default.
- Q63573214 P4844 Q63573214-F8CD749F-3CD6-49CC-9BC6-92581EC132A3 @default.
- Q63573214 P580 Q63573214-0E92543A-C63C-4C65-AA80-2384FE523F98 @default.
- Q63573214 P582 Q63573214-4399CF87-1727-4350-AE04-A2A8F70ECCA4 @default.
- Q63573214 P6099 Q63573214-223EB84A-E265-4BA9-8156-44EA16904379 @default.
- Q63573214 P6153 Q63573214-04892974-123C-457E-8835-EAC036C70407 @default.
- Q63573214 P6153 Q63573214-50F28434-A617-4478-B8BF-CFF0F8346080 @default.
- Q63573214 P6153 Q63573214-5777072D-EA59-49DE-9671-A6D812A23096 @default.
- Q63573214 P6153 Q63573214-8B2BC887-8EF5-4822-97EA-06A4F406D63E @default.
- Q63573214 P8363 Q63573214-E82CF73A-B0F3-49AF-84EA-76B8DD384960 @default.
- Q63573214 P859 Q63573214-BA605E63-3052-4CAB-A4F9-CA53AEFF9BFD @default.
- Q63573214 P1132 "+245" @default.
- Q63573214 P1476 "A Two-Part Phase Ib/II Study to Investigate the Pharmacokinetics, Efficacy, and Safety of Atezolizumab Subcutaneous in Patients With Stage IV Non-Small Cell Lung Cancer" @default.
- Q63573214 P17 Q142 @default.
- Q63573214 P17 Q145 @default.
- Q63573214 P17 Q211 @default.
- Q63573214 P17 Q29 @default.
- Q63573214 P17 Q298 @default.
- Q63573214 P17 Q36 @default.
- Q63573214 P17 Q38 @default.
- Q63573214 P17 Q664 @default.
- Q63573214 P2899 "+18" @default.
- Q63573214 P3098 "NCT03735121" @default.
- Q63573214 P31 Q30612 @default.
- Q63573214 P4844 Q20707748 @default.
- Q63573214 P4844 Q413299 @default.
- Q63573214 P4844 Q415588 @default.
- Q63573214 P4844 Q423762 @default.
- Q63573214 P580 "2018-12-27T00:00:00Z" @default.
- Q63573214 P582 "2021-04-22T00:00:00Z" @default.
- Q63573214 P6099 Q5452194 @default.
- Q63573214 P6153 Q1278898 @default.
- Q63573214 P6153 Q2451973 @default.
- Q63573214 P6153 Q4803501 @default.
- Q63573214 P6153 Q4916714 @default.
- Q63573214 P8363 Q78089383 @default.
- Q63573214 P859 Q212646 @default.